I've found two groups of articles that state different conclusions.
According to Aggarwal S, Ricklis RM, Williams SA, Denmeade SR, "Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human," (Prostate. 2006 Jun 15;66(9):903-10), "PSMA is not expressed in any significant amount in the prostates of mouse, beagle dog, or macaque monkeys in this study but is expressed in high levels by human prostate. These non-human species, therefore, are not suitable toxicologic models to assess prostate damage from PSMA-activated intraprostatic prodrug/protoxin therapies."
However, in the more recent article of Schmidt S, Fracasso G, Colombatti M, Naim HY, "Cloning and characterization of canine prostate-specific membrane antigen," (Prostate. 2013 May;73(6):642-50) it's stated that "We demonstrate that canine PSMA reveals similar characteristics to human PSMA rendering this protein useful as a translational model for investigations of prostate cancer as well as a suitable antigen for targeted therapy studies in dogs."
Another recent article below appears to support PSMA as well:
Lisa Y Wu, Jacqueline M Johnson, Jessica K Simmons, Desiree E Mendes, Jonathan J Geruntho, Tiancheng Liu, Wessel P Dirksen, Thomas J Rosol, William C Davis, Clifford E Berkman, "Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells," (Prostate, 74:451-457 (2014))
So, can somebody clarify if PSMA can be indeed a useful biomarker to target in the PC canine model? Thanks!